Related Experiment Videos
Cellular signalling mechanisms in adaptation to ischemia-induced myocardial damage
1Center for Physiological Gene Function, Institution of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden. Guro.Valen@cmm.ki.se
Insights
Brief heart preconditioning protects against damage from ischemia-reperfusion injury. This adaptive process involves trigger, signal transduction, and effector phases, offering potential therapeutic benefits for heart conditions.
Area of Science:
- Cardiology
- Cellular Biology
- Physiology
Background:
- Ischemic heart disease is a leading cause of death globally.
- Ischemia-reperfusion injury can lead to cardiomyocyte death via necrosis or apoptosis.
- Preconditioning, involving brief ischemia-reperfusion episodes, protects the heart against subsequent ischemic events.
Purpose of the Study:
- To explore the adaptive phenomenon of preconditioning in myocardial protection.
- To elucidate the complex mechanisms underlying preconditioning's protective effects.
- To highlight the therapeutic potential of understanding preconditioning.
Main Methods:
- Review of animal experiments and human evidence regarding preconditioning.
- Analysis of the distinct phases of preconditioning: trigger, signal transduction, and effector.
- Investigation into the molecular signaling pathways involved in myocardial adaptation.
Main Results:
- Preconditioning can be achieved both immediately before and days prior to an ischemic event.
- Protection via preconditioning can extend to other organs (remote preconditioning).
- Unstable angina in humans may represent a natural form of in vivo preconditioning.
Conclusions:
- Preconditioning is a complex adaptive process involving multiple phases and signaling cascades.
- Understanding preconditioning mechanisms is vital for developing therapeutic strategies against heart damage.
- Preconditioning offers a powerful, potentially natural, mode of myocardial protection against necrosis and apoptosis.
Abstract:
Ischemic heart disease is the major cause of morbidity and mortality in the Western world. Ischemia-reperfusion injury may induce cardiomyocyte cell death by necrosis or apoptosis. The heart can be adapted to tolerate an ischemic event by preceding brief episodes of ischemia and reperfusion, called preconditioning. Preconditioning protects the heart when it is directed towards the heart itself either immediately before or several days before an induced ischemic event. Adaptation by preconditioning can even be achieved in other organs, and preconditioning one organ can protect another organ. Evidence suggests that preconditioning may be a naturally occurring adaptive process in vivo, and in humans unstable angina before acute myocardial infarction may represent the phenomenon. The mechanisms underlying the response are complex and intertwined, and probably differ between acute and delayed. as well as local or remote models. Based on animal experiments, it appears that preconditioning consists of a trigger phase with release of signal substance(s), a signal transduction phase where cascade reactions are induced, and an organ effector phase where mediator(s) ensure organ protection against necrosis and apoptosis. Understanding the underlying mechanisms of action is crucial to making therapeutic use of this powerful mode of myocardial protection.